Nomura Healthcare Fund Class C DLHCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$25.02  /  −1.03%
  • Fund Size$792.8M
  • Adjusted Expense Ratio1.960%
  • Net Expense Ratio1.960%
  • Fee Level: DistributionAverage
  • Share Class TypeLevel Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Mid Value
  • Minimum Initial Investment$1,000
  • Investment StatusOpen
  • TTM Yield1.70%
  • Turnover Ratio4%

Morningstar’s Analysis DLHCX

Will DLHCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A mixed bag.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Macquarie Healthcare’s pros and cons continue to offset each other, and the strategy retains its Average People and Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DLHCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings39.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Pfizer Inc

4.5834M
Healthcare

AbbVie Inc

4.3533M
Healthcare

Gilead Sciences Inc

4.1731M
Healthcare

Merck & Co Inc

4.0631M
Healthcare

UCB SA

4.0230M
Healthcare

Eli Lilly and Co

4.0030M
Healthcare

Regeneron Pharmaceuticals Inc

3.8429M
Healthcare

UnitedHealth Group Inc

3.4226M
Healthcare

Illumina Inc

3.2825M
Healthcare

Elevance Health Inc

3.2624M
Healthcare

Sponsor Center